Bone Biologics

(NASDAQ) BBLG

Current Price$1.24

Market Cap$2.24M

Since IPO (2016)-100%

5 Year-100%

1 Year-74%

1 Month-6%

Bone Biologics Financials at a Glance

Market Cap

$2.24M

Revenue (TTM)

$0.00

Net Income (TTM)

-$2.86M

EPS (TTM)

-$2.51

P/E Ratio

-0.50

Dividend

$0.00

Beta (Volatility)

0.71 (Low)

Dividend

$0.00

Beta (Volatility)

0.71 (Low)

Price

$1.24

Volume

16,895

Open

$1.25

Price

$1.24

Volume

16,895

Open

$1.25

Previous Close

$1.25

Daily Range

$1.23 - $1.27

52-Week Range

$1.05 - $6.75

Estimated Earnings Date

Aug 13, 2026

Dividend

$0.00

Beta (Volatility)

0.71 (Low)

Price

$1.24

Volume

16,895

Open

$1.25

Previous Close

$1.25

Daily Range

$1.23 - $1.27

52-Week Range

$1.05 - $6.75

Estimated Earnings Date

Aug 13, 2026

BBLG News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Bone Biologics

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Jeffrey Frelick, MBA

Website

www.bonebiologics.com

Headquarters

Burlington, MA 01803, US

BBLG Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-75%

Return on Capital

-64%

Return on Assets

-57%

Earnings Yield

-2.00%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$2.24M

Shares Outstanding

1.80M

Volume

16.89K

Avg. Volume

12.49K

Financials (TTM)

Gross Profit

$0.00

Operating Income

-$3.23M

EBITDA

-$3.11M

Operating Cash Flow

-$2.69M

Capital Expenditure

$0.00

Free Cash Flow

-$2.69M

Cash & ST Invst.

$5.33M

Total Debt

$0.00

Bone Biologics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$2.24M

N/A

Market Cap/Employee

$1.12M

N/A

Employees

N/A

Net Income

-$765.99K

+24.7%

EBITDA

-$805.05K

+22.5%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$4.53M

+64.9%

Accounts Receivable

$7.81K

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-57.40%

N/A

Return on Invested Capital

-64.27%

N/A

Free Cash Flow

-$804.28K

+13.2%

Operating Cash Flow

-$804.28K

+13.2%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

INMInMed Pharmaceuticals Inc.

INMInMed Pharmaceuticals Inc.$1.58+1.28%

NAOVNanoVibronix, Inc.

NAOVNanoVibronix, Inc.$1.90+1.06%

NDRAENDRA Life Sciences Inc.

NDRAENDRA Life Sciences Inc.$4.23-11.32%

VEROVenus Concept Inc.

VEROVenus Concept Inc.$0.31+2.64%

BDRXBiodexa Pharmaceuticals Plc

BDRXBiodexa Pharmaceuticals Plc$3.36-2.04%

GCTKGlucoTrack, Inc.

GCTKGlucoTrack, Inc.$0.61-8.87%

HSCSHeartSciences Inc.

HSCSHeartSciences Inc.$1.94-2.27%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$14.38-0.13%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$73.05-0.14%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$43.19+0.14%

IBITiShares Bitcoin Trust

IBITiShares Bitcoin Trust$34.14-0.05%

AALAmerican Airlines Group

AALAmerican Airlines Group$13.50+0.02%

QQQInvesco QQQ Trust

QQQInvesco QQQ Trust$705.06-0.05%

ETHAiShares Ethereum Trust - iShares Ethereum Trust ETF

ETHAiShares Ethereum Trust - iShares Ethereum Trust ETF$11.87-0.11%

Questions About BBLG

What is the current price of Bone Biologics?

Bone Biologics is trading at $1.25 per share.

What is the 52-week range for Bone Biologics?

Over the past 52 weeks, Bone Biologics has traded between $1.05 and $6.75.

How much debt does Bone Biologics have?

As of the most recent reporting period, Bone Biologics reported total debt of $0.00.

How much cash does Bone Biologics have on hand?

Bone Biologics reported $4.53M in cash and cash equivalents in its most recent financial results.

What is Bone Biologics’s dividend yield?

Bone Biologics does not currently have a dividend yield.

Bone Biologics

Bone Biologics Financials at a Glance

BBLG News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Bone Biologics

BBLG Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Bone Biologics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About BBLG

What is the current price of Bone Biologics?

What is the 52-week range for Bone Biologics?

How much debt does Bone Biologics have?

How much cash does Bone Biologics have on hand?

What is Bone Biologics’s dividend yield?

Premium Investing Services